针对 CDKL5 缺乏症的基因替换方法的概念验证。
Proof-of-concept for a gene replacement approach to CDKL5 deficiency disorder.
机构信息
Neuroscience Institute, Children's Hospital Colorado, Aurora, CO, USA.
University of Colorado School of Medicine, Aurora, CO, USA.
出版信息
Brain. 2020 Mar 1;143(3):716-718. doi: 10.1093/brain/awaa055.
Abstract
This scientific commentary refers to ‘Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder’, by Gao (doi:10.1093/brain/awaa028).
摘要
这篇科学评论提到了 Gao 等人的研究“基因替代改善周期蛋白依赖性激酶样 5 障碍的小鼠和人类模型中的缺陷”（doi：10.1093/brain/awaa028）。
相似文献
1
Proof-of-concept for a gene replacement approach to CDKL5 deficiency disorder.针对 CDKL5 缺乏症的基因替换方法的概念验证。
Brain. 2020 Mar 1;143(3):716-718. doi: 10.1093/brain/awaa055.
2
Novel Cross-Correction-Enabled Gene Therapy for CDKL5-Deficiency Disorder.用于CDKL5缺陷障碍的新型启用交叉校正的基因疗法。
Neurotherapeutics. 2022 Oct;19(6):1878-1882. doi: 10.1007/s13311-022-01314-8. Epub 2022 Oct 20.
3
Aged heterozygous Cdkl5 mutant mice exhibit spontaneous epileptic spasms.老年杂合性 Cdkl5 突变小鼠表现出自发性癫痫痉挛。
Exp Neurol. 2020 Oct;332:113388. doi: 10.1016/j.expneurol.2020.113388. Epub 2020 Jun 22.
4
Hypermotor-tonic-spasms seizure sequence related to CDKL5 deficiency disorder: a typical case.与CDKL5缺乏症相关的运动亢进-张力亢进-痉挛发作序列：一例典型病例。
Epileptic Disord. 2022 Dec 1;24(6):1127-1128. doi: 10.1684/epd.2022.1480.
5
A potential new treatment for CDKL5 deficiency disorder.一种针对CDKL5缺乏症的潜在新疗法。
Lancet Neurol. 2022 May;21(5):394-395. doi: 10.1016/S1474-4422(22)00127-2.
6
Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder.针对CDKL5缺乏症的基因替代疗法的临床前研究。
Mol Ther. 2024 Oct 2;32(10):3331-3345. doi: 10.1016/j.ymthe.2024.07.012. Epub 2024 Jul 20.
7
Ganaxolone (Ztalmy) for CDKL5 deficiency disorder.用于治疗CDKL5缺乏症的甘氨酰环己酮（Ztalmy）。
Med Lett Drugs Ther. 2024 Aug 19;66(1709):e139-e140. doi: 10.58347/tml.2024.1709g.
8
Ganaxolone for management of seizures associated with CDKL5 deficiency disorder.甘氨酰胺用于治疗与CDKL5缺乏症相关的癫痫发作。
Trends Pharmacol Sci. 2023 Feb;44(2):128-129. doi: 10.1016/j.tips.2022.11.007. Epub 2022 Dec 12.
9
CDKL5 deficiency disorder: At the intersection between Rett syndrome and developmental epileptic encephalopathies.CDKL5缺乏症：处于雷特综合征与发育性癫痫性脑病的交叉点。
Dev Med Child Neurol. 2024 Apr;66(4):410-411. doi: 10.1111/dmcn.15797. Epub 2023 Oct 26.
10
Molecular and Synaptic Bases of CDKL5 Disorder.CDKL5 障碍的分子和突触基础。
Dev Neurobiol. 2019 Jan;79(1):8-19. doi: 10.1002/dneu.22639. Epub 2018 Oct 19.
引用本文的文献
1
CDKL5 sculpts functional callosal connectivity to promote cognitive flexibility.CDKL5 塑造功能性胼胝体连接以促进认知灵活性。
Mol Psychiatry. 2024 Jun;29(6):1698-1709. doi: 10.1038/s41380-023-01962-y. Epub 2023 Feb 3.
2
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder.分泌型、穿膜的 CDKL5 蛋白的表达增强了 CDKL5 缺乏症基因治疗的疗效。
Neurotherapeutics. 2022 Oct;19(6):1886-1904. doi: 10.1007/s13311-022-01295-8. Epub 2022 Sep 15.
3
Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder.影响 CDKL5 缺乏症患儿主要运动里程碑达成的因素。
Eur J Hum Genet. 2023 Feb;31(2):169-178. doi: 10.1038/s41431-022-01163-1. Epub 2022 Aug 18.
4
Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder.CDKL5 缺乏症中脑功能的电生理生物标志物。
Brain Commun. 2022 Aug 4;4(4):fcac197. doi: 10.1093/braincomms/fcac197. eCollection 2022.
5
CDKL5 deficiency disorder: clinical features, diagnosis, and management.CDKL5 缺乏症：临床特征、诊断与管理。
Lancet Neurol. 2022 Jun;21(6):563-576. doi: 10.1016/S1474-4422(22)00035-7. Epub 2022 Apr 25.
6
Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits.时间操纵 Cdkl5 揭示了其发育后关键功能和可逆转的 CDKL5 缺乏症相关缺陷。
J Clin Invest. 2021 Oct 15;131(20). doi: 10.1172/JCI143655.
7
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.CDKL5 缺乏症的当前神经治疗和新兴疗法。
J Neurodev Disord. 2021 Sep 16;13(1):40. doi: 10.1186/s11689-021-09384-z.
本文引用的文献
1
Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder.基因替换可改善周期蛋白依赖性激酶样 5 障碍的小鼠和人类模型中的缺陷。
Brain. 2020 Mar 1;143(3):811-832. doi: 10.1093/brain/awaa028.
2
CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.CDKL5 缺乏症：基因型、癫痫、皮质性视觉障碍与发育的关系。
Epilepsia. 2019 Aug;60(8):1733-1742. doi: 10.1111/epi.16285. Epub 2019 Jul 16.
3
Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.儿童起病遗传性癫痫的发病率和表型：一项前瞻性基于人群的全国队列研究。
Brain. 2019 Aug 1;142(8):2303-2318. doi: 10.1093/brain/awz195.
4
Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.周期素依赖性激酶样 5 缺乏症：临床综述。
Pediatr Neurol. 2019 Aug;97:18-25. doi: 10.1016/j.pediatrneurol.2019.02.015. Epub 2019 Feb 23.
5
Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes.高纯度大麻二酚（Epidiolex®）在患有CDKL5缺乏症、艾卡里迪综合征、Dup15q综合征和杜斯综合征患者中的开放标签使用。
Epilepsy Behav. 2018 Sep;86:131-137. doi: 10.1016/j.yebeh.2018.05.013. Epub 2018 Jul 11.
6
Characterisation of CDKL5 Transcript Isoforms in Human and Mouse.人类和小鼠中CDKL5转录本异构体的特征分析
PLoS One. 2016 Jun 17;11(6):e0157758. doi: 10.1371/journal.pone.0157758. eCollection 2016.
7
Incidence of Dravet Syndrome in a US Population.美国人群中德雷维特综合征的发病率。
Pediatrics. 2015 Nov;136(5):e1310-5. doi: 10.1542/peds.2015-1807. Epub 2015 Oct 5.
8
Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.患有CDKL5基因重复的男性和女性的神经发育和神经行为特征。
Eur J Hum Genet. 2015 Jul;23(7):915-21. doi: 10.1038/ejhg.2014.217. Epub 2014 Oct 15.
9
Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.系统递送 MeCP2 可挽救雷特综合征雌性小鼠模型的行为和细胞缺陷。
J Neurosci. 2013 Aug 21;33(34):13612-20. doi: 10.1523/JNEUROSCI.1854-13.2013.
10
Preclinical research in Rett syndrome: setting the foundation for translational success.Rett 综合征的临床前研究：为转化成功奠定基础。
Dis Model Mech. 2012 Nov;5(6):733-45. doi: 10.1242/dmm.011007.
Zotero 插件